US Patent Litigations are now available. Check here

EP2563906

NOVARTIS
Application Number
EP11715933A
Filing Date
Apr 25, 2011
Status
Revoked
Oct 28, 2024
Grant Date
Nov 8, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2563906B1 was granted on Nov 8, 2017 by Novartis The patent is currently Revoked.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO8700195
N/A
OppositionUS5122469
N/A
OppositionWO2006026408
N/A
OppositionWO2006026445
N/A
OppositionWO9845411
N/A
OppositionWO2006026447
N/A
OppositionUS6924124
N/A
OppositionWO2011134919
N/A
OppositionWO2008141207
N/A
OppositionWO2008121616
N/A
OppositionUS5672502
N/A
OppositionUS2008081356
N/A
OppositionUS2008182297
N/A
OppositionEP1757700
N/A
OppositionWO9512664
N/A
OppositionWO2008131374
N/A
OppositionUS5871999
N/A
OppositionUS2005019859
N/A
OppositionUS2006148074
N/A
OppositionUS2007184529
N/A
OppositionWO2008013809
N/A
OppositionUS2008070280
N/A
OppositionWO2008055260
N/A
OppositionUS2008108553
N/A
OppositionUS2008269132
N/A
OppositionUS2009123975
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.